AVITA Medical, Inc. (RCEL)
13.80
+0.66
(+5.02%)
USD |
NASDAQ |
Oct 20, 16:00
14.02
+0.22
(+1.59%)
After-Hours: 06:51
AVITA Medical Gross Profit (TTM) : 61.68M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.68M |
| March 31, 2026 | 58.86M |
| December 31, 2025 | 58.82M |
| September 30, 2025 | 60.63M |
| June 30, 2025 | 63.11M |
| March 31, 2025 | 61.25M |
| December 31, 2024 | 55.16M |
| September 30, 2024 | 51.43M |
| June 30, 2024 | 46.61M |
| March 31, 2024 | 43.07M |
| December 31, 2023 | 42.36M |
| September 30, 2023 | 38.07M |
| June 30, 2023 | 34.10M |
| March 31, 2023 | 31.50M |
| December 31, 2022 | 28.38M |
| September 30, 2022 | 28.52M |
| June 30, 2022 | 27.58M |
| March 31, 2022 | 24.91M |
| June 30, 2021 | 23.28M |
| March 31, 2021 | 18.04M |
| December 31, 2020 | 11.42M |
| September 30, 2020 | 7.134M |
| June 30, 2020 | 3.003M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 1.271B |
| Iovance Biotherapeutics, Inc. | 120.66M |
| Agenus, Inc. | 127.32M |
| Amgen, Inc. | 27.78B |
| Editas Medicine, Inc. | 44.58M |